⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 31, 2026

ReFacto AF 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)

📷 EU Safety Watch placeholder
ReFacto AF 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)
📷 EU Safety Watch placeholder
Refacto AF 1000 IU powder and solvent for solution for injection in a pre-filled syringe 1000 IU (powder and solvent for solution for injection) Parallel export ban in effect.
⚠️
Shortage ongoing
GERINNUNGSFAKTOR VIII is currently in short supply in AT.
📈 Timeline
10 days active so far
September 1, 2026 September 10, 2026

What is this? This is a medicine called ReFacto AF. It is a powder and liquid that you mix to make an injection. It helps people whose blood does not clot well.

What's happening? The medicine is not available right now. A supply ban is in place to stop extra amounts leaving the country.

Does this affect me? If you use this medicine, you may not be able to get it until supplies return.

What should I do? Ask your pharmacist or doctor for advice. They can help find a solution or another treatment.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: B02BD02 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Pfizer Europe Ma EEIG, Boulevard De La Plaine 17, 1050 Brussels, Kingdom of Belgium · Affected packs: 1 Stück Fertigspritze, Schachtel [Nicht verfügbar, since 2026-08-31]

First published
August 31, 2026
Last refreshed by us
14 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
ReFacto AF 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung). Refacto AF 1000 IU powder and solvent for solution for injection in a pre-filled syringe 1000 IU (powder and solvent for solution for injection) Parallel export ban in effect.
When was this alert issued?
This alert was issued on August 31, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.